
William C. Huang, MD, discusses data on mitomycin for intravesical solution from the pivotal ENVISION trial and the OPTIMA II study.
William C. Huang is a urologic oncologist at NYU Langone Medical Center in New York, New York.

William C. Huang, MD, discusses data on mitomycin for intravesical solution from the pivotal ENVISION trial and the OPTIMA II study.

William C. Huang, MD, highlights data from a long-term extension study of the OPTIMA II trial.